The global electronic stethoscope market size was estimated to be USD 183.5 million in 2023 and is expected to reach at USD 365.7 million by 2034 with a CAGR of 6.47% during the forecast period 2024-2034. Growing prevalence of chronic diseases such as cardiovascular & respiratory diseases, increasing geriatric population, rising adoption of cutting-edge technology such as artificial intelligence in stethoscopes, surge in technological advancements, growing demand for stethoscope with an electrocardiogram (ECG), increasing adoption of unhealthy lifestyle patterns among population, rising usage of telemedicine, and surge in launch of advanced AI-based electronic stethoscope are some of the main elements driving the market's expansion.
Surge in launch of advanced AI-based electronic stethoscope is predicted to boost the market growth during the forecast period. Electronic stethoscopes come equipped with computer-aided auscultation programs or software, which assist in recording and visualizing sounds to facilitate precise and early disease diagnosis. The swift digitization within the healthcare sector has heightened the need for advanced technological instruments. For instance, in January 2023, At CES 2023, Smartsound introduced a groundbreaking series of AI-powered stethoscopes. This series, comprising three models known as Skeeper R1, H1, and P1, is claimed by the company to be the world's first of its kind.
By product, digitalization stethoscope was the highest revenue-grossing segment in the global electronic stethoscope market in 2023 owing to increasing advancement of Bluetooth technology, growing demand for digital stethoscopes with ECG & other parameters, and rising launch of new devices. For instance, in June 2023, Eko Health, a prominent pioneer in digital health technology for detecting heart and lung diseases, has revealed the introduction of its advanced digital stethoscope, known as CORE 500. Additionally, amplifying stethoscope is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements and surge in demand for advanced devices.
By technology, wireless transmission system was the highest revenue-grossing segment in the global electronic stethoscope market in 2023 owing to the advantages of convenience, surge in adoption of technological advancements by healthcare professionals, and growing focus on development of wireless devices. Additionally, integrated chest-piece system is predicted to grow at fastest CAGR during the forecast period owing to its higher sensitivity & accuracy, increasing adoption of microelectromechanical system (MEMS), and surge in collaborations within market players to launch advanced devices. For instance, in May 2023, The direct-to-consumer healthcare apparel and lifestyle brand, FIGS, Inc., along with Eko Health, Inc., a prominent innovator in digital health technology specializing in heart and lung disease detection, have jointly revealed the introduction of the FIGS | Eko CORE 500TM Digital Stethoscope.
By application, cardiology was the highest revenue-grossing segment in the global electronic stethoscope market in 2023 owing to the rising prevalence of cardiovascular diseases (CVD), increasing demand for early diagnosis of the cardiac diseases, and growing approvals by regulatory bodies. For instance, in April 2022, The FDA has granted approval for clinical use of the Al-ready VoqX, the world's first stethoscope capable of detecting infrasound-acoustic waves that are beyond the range of human hearing. This innovative device is developed by the Israeli company Sanolla, known for its AI-powered primary care diagnostic tools. Following the Israeli Health Ministry's regulatory clearance, the FDA has also given its approval. With these regulatory endorsements in place, Sanolla can now make the VoqX available for clinical use in both the United States and Israel. Their objective is to entirely replace traditional stethoscopes from previous generations with this intelligent infrasound stethoscope. Additionally, general medicine is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of surgical procedures and growing demand of stethoscope by general physician.
By end-user, hospitals was the highest revenue-grossing segment in the global electronic stethoscope market in 2023 owing to the increase in chronic illnesses is resulting in a significant rise in hospital admissions, growing demand by hospitals, and rising launch of new devices. For instance, in June 2023, Eko Health has revealed both FDA clearance and the release of Core 500, a next-generation digital stethoscope that employs artificial intelligence to identify irregular heart rhythms. This device integrates AI software, high-quality audio, a full-color display, and a 3-lead ECG for enhanced capabilities. Additionally, clinics is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of patient pool and growing need for advanced & user-friendly stethoscope devices in clinics.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing adoption of technological advancements in devices, growing prevalence of chronic disorders, rising geriatric population, surge in healthcare expenditure, the presence of well-established healthcare infrastructure, and increasing partnerships within market players. For instance, in August 2022, Caregility, a company specializing in enterprise telehealth platforms, and Eko, a leading provider of telehealth stethoscopes, have announced a partnership to integrate their services. This collaboration enables users of Caregility's iConsult application to conduct advanced auscultation (listening for heart, lung, and other body sounds) as part of virtual physical examinations. The integration involves connecting Caregility's cloud platform with Eko's intelligent stethoscopes and software, enhancing the capabilities of virtual patient assessments. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of cardiovascular diseases & acute ischemic stroke, increasing unhealthy lifestyle among population, rising investments for research & development activities, growing launch of advanced products. For instance, in May 2022, 3M TM Littmann@ has disclosed that its 3M TM Littmann@ CORE Digital Stethoscope was given an honorable mention in the health category of the 2022 Fast Company World Changing Ideas global awards program.
Surge in launch of advanced AI-based electronic stethoscope is predicted to boost the market growth during the forecast period. Electronic stethoscopes come equipped with computer-aided auscultation programs or software, which assist in recording and visualizing sounds to facilitate precise and early disease diagnosis. The swift digitization within the healthcare sector has heightened the need for advanced technological instruments. For instance, in January 2023, At CES 2023, Smartsound introduced a groundbreaking series of AI-powered stethoscopes. This series, comprising three models known as Skeeper R1, H1, and P1, is claimed by the company to be the world's first of its kind.
By product, digitalization stethoscope was the highest revenue-grossing segment in the global electronic stethoscope market in 2023 owing to increasing advancement of Bluetooth technology, growing demand for digital stethoscopes with ECG & other parameters, and rising launch of new devices. For instance, in June 2023, Eko Health, a prominent pioneer in digital health technology for detecting heart and lung diseases, has revealed the introduction of its advanced digital stethoscope, known as CORE 500. Additionally, amplifying stethoscope is predicted to grow at fastest CAGR during the forecast period owing to the growing technological advancements and surge in demand for advanced devices.
By technology, wireless transmission system was the highest revenue-grossing segment in the global electronic stethoscope market in 2023 owing to the advantages of convenience, surge in adoption of technological advancements by healthcare professionals, and growing focus on development of wireless devices. Additionally, integrated chest-piece system is predicted to grow at fastest CAGR during the forecast period owing to its higher sensitivity & accuracy, increasing adoption of microelectromechanical system (MEMS), and surge in collaborations within market players to launch advanced devices. For instance, in May 2023, The direct-to-consumer healthcare apparel and lifestyle brand, FIGS, Inc., along with Eko Health, Inc., a prominent innovator in digital health technology specializing in heart and lung disease detection, have jointly revealed the introduction of the FIGS | Eko CORE 500TM Digital Stethoscope.
By application, cardiology was the highest revenue-grossing segment in the global electronic stethoscope market in 2023 owing to the rising prevalence of cardiovascular diseases (CVD), increasing demand for early diagnosis of the cardiac diseases, and growing approvals by regulatory bodies. For instance, in April 2022, The FDA has granted approval for clinical use of the Al-ready VoqX, the world's first stethoscope capable of detecting infrasound-acoustic waves that are beyond the range of human hearing. This innovative device is developed by the Israeli company Sanolla, known for its AI-powered primary care diagnostic tools. Following the Israeli Health Ministry's regulatory clearance, the FDA has also given its approval. With these regulatory endorsements in place, Sanolla can now make the VoqX available for clinical use in both the United States and Israel. Their objective is to entirely replace traditional stethoscopes from previous generations with this intelligent infrasound stethoscope. Additionally, general medicine is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of surgical procedures and growing demand of stethoscope by general physician.
By end-user, hospitals was the highest revenue-grossing segment in the global electronic stethoscope market in 2023 owing to the increase in chronic illnesses is resulting in a significant rise in hospital admissions, growing demand by hospitals, and rising launch of new devices. For instance, in June 2023, Eko Health has revealed both FDA clearance and the release of Core 500, a next-generation digital stethoscope that employs artificial intelligence to identify irregular heart rhythms. This device integrates AI software, high-quality audio, a full-color display, and a 3-lead ECG for enhanced capabilities. Additionally, clinics is predicted to grow at fastest CAGR during the forecast period owing to the surge in number of patient pool and growing need for advanced & user-friendly stethoscope devices in clinics.
North America region is anticipated for the highest revenue share during the forecast period owing to the increasing adoption of technological advancements in devices, growing prevalence of chronic disorders, rising geriatric population, surge in healthcare expenditure, the presence of well-established healthcare infrastructure, and increasing partnerships within market players. For instance, in August 2022, Caregility, a company specializing in enterprise telehealth platforms, and Eko, a leading provider of telehealth stethoscopes, have announced a partnership to integrate their services. This collaboration enables users of Caregility's iConsult application to conduct advanced auscultation (listening for heart, lung, and other body sounds) as part of virtual physical examinations. The integration involves connecting Caregility's cloud platform with Eko's intelligent stethoscopes and software, enhancing the capabilities of virtual patient assessments. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the surge in prevalence of cardiovascular diseases & acute ischemic stroke, increasing unhealthy lifestyle among population, rising investments for research & development activities, growing launch of advanced products. For instance, in May 2022, 3M TM Littmann@ has disclosed that its 3M TM Littmann@ CORE Digital Stethoscope was given an honorable mention in the health category of the 2022 Fast Company World Changing Ideas global awards program.
Segmentation: Electronic Stethoscope Market Report 2023 - 2034
Electronic Stethoscope Market Analysis & Forecast by Product 2023 - 2034 (Revenue USD Mn)
- Digitalization Stethoscope
- Amplifying Stethoscope
Electronic Stethoscope Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Mn)
- Wireless Transmission System
- Integrated Chest-Piece System
- Integrated Receiver Head-Piece System
Electronic Stethoscope Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Mn)
- Telemedicine
- Pediatrics
- General Medicine
- Cardiology
- Veterinary
Electronic Stethoscope Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Mn)
- Clinics
- Hospitals
- Others
Electronic Stethoscope Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Mn)
- North America
- U.S.
- Canada
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
- Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
- Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Electronic Stethoscope Market: Product Estimates & Trend Analysis
8. Electronic Stethoscope Market: Technology Estimates & Trend Analysis
9. Electronic Stethoscope Market: Application Estimates & Trend Analysis
10. Electronic Stethoscope Market: End-user Estimates & Trend Analysis
11. Regional Market Analysis
12. North America Electronic Stethoscope Market
13. Europe Global Electronic Stethoscope Market
14. Asia Pacific Global Electronic Stethoscope Market
15. Latin America Global Electronic Stethoscope Market
16. MEA Global Electronic Stethoscope Market
17. Competitor Analysis
18. Company Profiles
Companies Mentioned
- Eko
- Contec Medical Systems Co. Ltd.
- 3M
- Thinklabs Medical LLC
- Meditech Equipment Co. Ltd.
- Cardionics
- eKuore
- Ayu Devices
- HD Medical
- American Diagnostic Corporation
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 200 |
| Published | January 2024 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 183.5 Million |
| Forecasted Market Value ( USD | $ 356.7 Million |
| Compound Annual Growth Rate | 6.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 10 |
